Cargando…
First person – Kaitly Woodard
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Kaitly Woodard is first author on ‘ Limitations of mouse models for sickle cell disease con...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277143/ http://dx.doi.org/10.1242/dmm.049644 |
_version_ | 1784745887536250880 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Kaitly Woodard is first author on ‘ Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations’, published in DMM. Kaitly conducted the research described in this article while a graduate student in Mitchell J. Weiss's lab at St. Jude Children's Research Hospital, Memphis, TN, USA. She is now a Senior Scientist II in the lab of Mir Hossain at Novartis Institutes for BioMedical Research, Cambridge, MA, USA, investigating gene therapy for haemoglobinopathies. |
format | Online Article Text |
id | pubmed-9277143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-92771432022-07-13 First person – Kaitly Woodard Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Kaitly Woodard is first author on ‘ Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations’, published in DMM. Kaitly conducted the research described in this article while a graduate student in Mitchell J. Weiss's lab at St. Jude Children's Research Hospital, Memphis, TN, USA. She is now a Senior Scientist II in the lab of Mir Hossain at Novartis Institutes for BioMedical Research, Cambridge, MA, USA, investigating gene therapy for haemoglobinopathies. The Company of Biologists Ltd 2022-07-07 /pmc/articles/PMC9277143/ http://dx.doi.org/10.1242/dmm.049644 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Kaitly Woodard |
title | First person – Kaitly Woodard |
title_full | First person – Kaitly Woodard |
title_fullStr | First person – Kaitly Woodard |
title_full_unstemmed | First person – Kaitly Woodard |
title_short | First person – Kaitly Woodard |
title_sort | first person – kaitly woodard |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277143/ http://dx.doi.org/10.1242/dmm.049644 |